Allergy Therapeutics plc

OTCPK:AGYT.F Stock Report

Market Cap: US$470.1m

Allergy Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

OTCPK:AGYT.F Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
02 Mar 26SellUS$170,256,209ZQ Capital Hong Kong LimitedCompany4,247,775,524US$0.15
25 Feb 26BuyUS$142,050,273Skygem Acquisition LimitedCompany4,038,175,524US$0.15
25 Feb 26BuyUS$58,453,294ZQ Capital Hong Kong LimitedCompany1,893,776,143US$0.031
25 Feb 26SellUS$58,453,294Skygem Acquisition LimitedCompany1,893,776,143US$0.031

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of AGYT.F?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders9,167,7070.145%
Public Companies26,719,5770.422%
General Public263,136,7864.16%
Institutions432,435,2796.83%
Private Companies1,770,344,01128%
VC/PE Firms3,830,726,19060.5%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 32.9%.


Top Shareholders

Top 25 shareholders own 95.69% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
60.5%
ZQ Capital Hong Kong Limited
3,830,726,190US$284.4m0.05%no data
27.5%
Beagle Partners Llp
1,741,647,408US$129.3m0%no data
3.02%
KKR & Co. Inc.
191,089,599US$14.2m0%0.13%
0.99%
Interactive Brokers Group, Inc.
62,502,355US$4.6m3.09%0.07%
0.76%
Hargreaves Lansdown Asset Management Ltd.
47,828,687US$3.6m0.19%0.01%
0.71%
Amundi Asset Management SAS
44,990,000US$3.3m10.2%no data
0.45%
Aberdeen Group Plc
28,337,391US$2.1m-3.25%no data
0.25%
TEAM plc
15,565,000US$1.2m0%no data
0.22%
West Yorkshire Pension Fund
13,877,871US$1.0m0%0.02%
0.21%
Hbos Investment Fund Managers Limited
13,318,757US$988.7k-4.46%no data
0.19%
Barclays Bank Plc
12,199,186US$905.6k-11.9%no data
0.16%
GSK plc
10,118,748US$751.2k0%0.02%
0.13%
IG Group Holdings plc
8,022,417US$595.6k-3.04%0.03%
0.079%
Manuel Llobet
5,001,200US$371.3k0%no data
0.079%
Santander Asset Management Sgiic
4,994,532US$370.8k-6.72%no data
0.073%
Pictet Asset Management Limited
4,610,000US$342.2k0%no data
0.066%
Bank Julius Bär & Co. AG
4,205,533US$312.2k0%no data
0.062%
Hsbc Global Asset Management (uk) Limited
3,933,314US$292.0k-0.1%no data
0.061%
Raiffeisenlandesbank Oberösterreich Aktiengesellschaft
3,874,312US$287.6k0%0.01%
0.059%
Commerzbank AG
3,716,544US$275.9k-12.2%no data
0.033%
Peter Jensen
2,100,000US$155.9k0%no data
0.03%
Anthony Parker
1,925,000US$142.9k0%no data
0.029%
Trb Holdings Ltd
1,840,000US$136.6k0%no data
0.027%
UBS Asset Management AG
1,684,111US$125.0k-1.17%no data
0.024%
TrinityBridge Limited
1,520,137US$112.9k-8.46%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/08/09 17:49
End of Day Share Price 2026/07/02 00:00
Earnings2025/12/31
Annual Earnings2025/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Allergy Therapeutics plc is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Adam McCarterCavendish
Paul CuddonPeel Hunt LLP
Mohammad FazeliPiper Sandler Companies